CH638982A5 - Composition anticancereuse pour l'administration par d'autres voies que l'injection. - Google Patents

Composition anticancereuse pour l'administration par d'autres voies que l'injection. Download PDF

Info

Publication number
CH638982A5
CH638982A5 CH561979A CH561979A CH638982A5 CH 638982 A5 CH638982 A5 CH 638982A5 CH 561979 A CH561979 A CH 561979A CH 561979 A CH561979 A CH 561979A CH 638982 A5 CH638982 A5 CH 638982A5
Authority
CH
Switzerland
Prior art keywords
ara
ester
cmp
composition according
arabinofuranosylcytosine
Prior art date
Application number
CH561979A
Other languages
English (en)
French (fr)
Inventor
Kenjiro Kodama
Akira Kuninaka
Mineo Saneyoshi
Original Assignee
Yamasa Shoyu Kk
Mineo Saneyoshi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu Kk, Mineo Saneyoshi filed Critical Yamasa Shoyu Kk
Publication of CH638982A5 publication Critical patent/CH638982A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CH561979A 1978-06-20 1979-06-15 Composition anticancereuse pour l'administration par d'autres voies que l'injection. CH638982A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7369878A JPS552601A (en) 1978-06-20 1978-06-20 Anti-tumor agent for non-injection use

Publications (1)

Publication Number Publication Date
CH638982A5 true CH638982A5 (fr) 1983-10-31

Family

ID=13525685

Family Applications (1)

Application Number Title Priority Date Filing Date
CH561979A CH638982A5 (fr) 1978-06-20 1979-06-15 Composition anticancereuse pour l'administration par d'autres voies que l'injection.

Country Status (9)

Country Link
US (1) US4542021A (cg-RX-API-DMAC7.html)
JP (1) JPS552601A (cg-RX-API-DMAC7.html)
CH (1) CH638982A5 (cg-RX-API-DMAC7.html)
DE (1) DE2924691A1 (cg-RX-API-DMAC7.html)
FR (1) FR2429019A1 (cg-RX-API-DMAC7.html)
GB (1) GB2023422B (cg-RX-API-DMAC7.html)
IT (1) IT1206968B (cg-RX-API-DMAC7.html)
NL (1) NL190955C (cg-RX-API-DMAC7.html)
SE (1) SE455162B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS552602A (en) * 1978-06-20 1980-01-10 Yamasa Shoyu Co Ltd 1-beta-d-arabinofranosylcytosine-5'-phosphoric acid oleyl ester
EP0081386B1 (en) * 1981-12-09 1985-05-29 Teijin Limited 5-fluoro-2'-deoxyuridine derivatives and a process for the preparation thereof
JPS58225097A (ja) * 1982-06-23 1983-12-27 Yamasa Shoyu Co Ltd ヌクレオシド5′−アルキルもしくはアルケニルりん酸
JPS5925327A (ja) * 1982-07-31 1984-02-09 Hidematsu Hirai 抗腫瘍性複合体の製造方法
DE3773716D1 (de) * 1986-03-24 1991-11-21 Nippon Kayaku Kk Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
ES2160582T3 (es) * 1992-04-03 2001-11-16 Nippon Kayaku Kk Capsula dura de ocfosfato de citarabina.
DE4402492A1 (de) * 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Herstellung von unsymmetrischen Phosphorsäurediestern
GB2389788B (en) * 2000-12-23 2005-07-20 Univ Creighton Methods for inducing apoptosis and inhibiting proliferation in cancer cells
US20040072902A1 (en) * 2001-12-24 2004-04-15 Adrian Thomas E. Methods for inducing apoptosis and inhibiting proliferation in cancer cells
US7524831B2 (en) * 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
CN102115485A (zh) * 2009-12-30 2011-07-06 济南圣鲁金药物技术开发有限公司 基于阿糖胞苷结构的前药及其合成方法及应用
SG10201804835VA (en) 2013-10-11 2018-07-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792447C3 (de) * 1968-09-04 1978-05-11 Fa. Heinrich Mack Nachf., 7919 Au Oral anwendbares, cytostatisches Mittel
DE2438322C3 (de) * 1974-08-09 1979-02-08 Chemische Werke Huels Ag, 4370 Marl Verfahren zur Herstellung von Polymerisaten mit breiter Molekulargewichtsverteilung
FR2287910A1 (fr) * 1974-10-15 1976-05-14 Asahi Chemical Ind Derives nucleotidiques et procede de preparation de ceux-ci
JPS5289681A (en) * 1976-01-22 1977-07-27 Yamasa Shoyu Co Ltd Preparation of aracytidine -5# phosphoric acid ester derivatives
JPS552602A (en) * 1978-06-20 1980-01-10 Yamasa Shoyu Co Ltd 1-beta-d-arabinofranosylcytosine-5'-phosphoric acid oleyl ester

Also Published As

Publication number Publication date
JPS5748091B2 (cg-RX-API-DMAC7.html) 1982-10-14
FR2429019A1 (fr) 1980-01-18
FR2429019B1 (cg-RX-API-DMAC7.html) 1982-11-05
GB2023422A (en) 1980-01-03
US4542021A (en) 1985-09-17
NL190955B (nl) 1994-06-16
JPS552601A (en) 1980-01-10
DE2924691A1 (de) 1980-01-17
NL7904771A (nl) 1979-12-27
DE2924691C2 (cg-RX-API-DMAC7.html) 1991-10-10
GB2023422B (en) 1983-01-06
IT7949442A0 (it) 1979-06-18
SE7905375L (sv) 1979-12-21
IT1206968B (it) 1989-05-17
NL190955C (nl) 1994-11-16
SE455162B (sv) 1988-06-27

Similar Documents

Publication Publication Date Title
EP0078785B1 (fr) Sels d'acide valproîque, leur préparation et leur utilisation
CH638982A5 (fr) Composition anticancereuse pour l'administration par d'autres voies que l'injection.
CH651551A5 (fr) Derives de l'indole, leur preparation et compositions pharmaceutiques les contenant.
MC1174A1 (fr) Nouveaux nucleosides et procede pour leur preparation
Lupascu et al. Development, optimization and biological evaluation of chitosan scaffold formulations of new xanthine derivatives for treatment of type-2 diabetes mellitus
FR2924430A1 (fr) Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation
EP2321323B9 (fr) Derives dimeriques d'artemisinine et application en therapie anticancereuse
BE1001621A3 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments.
FR2612517A1 (fr) Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant
MC2278A1 (fr) Nouveaux derives puriques
MC1984A1 (fr) Derives de la purine
FR2898272A1 (fr) Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur
MC1036A1 (fr) Procédé de préparation de composés de mercaptopyrrole condensés
LU83928A1 (fr) Acides amino-2 halogenobenzoyl-3 methyphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques
WO2003035663A1 (fr) Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA1140155A (fr) PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU 1.alpha.,25-DIHYDROXY CHOLECALCIFEROL
FR2500454A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
WO2001036437A1 (fr) DERIVES DE β-D-5-THIOXYLOSE, PROCEDE DE PREPARATION ET UTILISATION EN THERAPEUTIQUE
EP0143675B1 (fr) Nouveaux dérivés de nitrosourée, leur procédé de préparation et compositions pharmaceutiques les contenant
EP0126013B1 (fr) Dithiodiacétamides cycliques, procédé pour leur préparation et compositions pharmaceutiques en contenant
BE883963A (fr) Derives du benzimidazole et compositions pharmaceutiques les contenant
CA2212956A1 (fr) Derives triaryloxyacetyl d'epipodophyllotoxines, leur procede de preparation et leur utilisation comme medicaments anticancereux
EP0408727A1 (fr) Derives glycosyl phospholipidiques de nucleosides et leur application en tant que medicaments
BE844136A (fr) Nouveaux derives de la 5-fluoropyrimidin-4-one
BE835759A (fr) Nouveaux dibenzocycloheptenes a portion cycloprupyle condensee, leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
PL Patent ceased